BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 14503344)

  • 1. A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc.
    Kadoya H; Uchida A; Kashihara N
    Ther Apher Dial; 2016 Aug; 20(4):422-3. PubMed ID: 26948531
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
    Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
    Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
    Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
    J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
    Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
    Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
    Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
    J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of polaprezinc-induced pneumonitis].
    Eto S; Yoshinaga T; Ushijima S; Saishoji T
    Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):561-4. PubMed ID: 14503344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of zinc complex of L-carnosine for medical use.
    Matsukura T; Tanaka H
    Biochemistry (Mosc); 2000 Jul; 65(7):817-23. PubMed ID: 10951100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polaprezinc].
    Kuwayama H; Takahashi M; Suzuki K; Suga M; Takata H; Ohara T; Koizumi K; Kiriyama Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():717-20. PubMed ID: 11979877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of polaprezinc research].
    Takei M
    Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review.
    Doi H; Kuribayashi K; Kijima T
    Future Oncol; 2018 Aug; 14(19):1977-1988. PubMed ID: 30074413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic approaches to peptic ulcer using mucosal protective agents].
    Jin M; Otaka M; Watanabe S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():377-81. PubMed ID: 11979810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isoniazid-induced pneumonitis].
    Hatakeyama S; Tatibana A; Suzuki K; Okano H; Oka T
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):448-52. PubMed ID: 9742862
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.